Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine
Crossref DOI link: https://doi.org/10.1186/s12883-015-0353-x
Published Online: 2015-07-03
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blumenfeld, Andrew M.
Aurora, Sheena K.
Laranjo, Karen
Papapetropoulos, Spyros
License valid from 2015-07-03
Article History
Received: 15 April 2014
Accepted: 11 June 2015
First Online: 3 July 2015